Literature DB >> 29212937

Experimental Adaptive Evolution of Simian Immunodeficiency Virus SIVcpz to Pandemic Human Immunodeficiency Virus Type 1 by Using a Humanized Mouse Model.

Kei Sato1,2,3, Naoko Misawa4,2, Junko S Takeuchi4, Tomoko Kobayashi4, Taisuke Izumi4,2, Hirofumi Aso2,5, Shumpei Nagaoka2,6, Keisuke Yamamoto2,7, Izumi Kimura2,8, Yoriyuki Konno2,6, Yusuke Nakano4,2, Yoshio Koyanagi4,2.   

Abstract

Human immunodeficiency virus type 1 (HIV-1), the causative agent of AIDS, originated from simian immunodeficiency virus from chimpanzees (SIVcpz), the precursor of the human virus, approximately 100 years ago. This indicates that HIV-1 has emerged through the cross-species transmission of SIVcpz from chimpanzees to humans. However, it remains unclear how SIVcpz has evolved into pandemic HIV-1 in humans. To address this question, we inoculated three SIVcpz strains (MB897, EK505, and MT145), four pandemic HIV-1 strains (NL4-3, NLCSFV3, JRCSF, and AD8), and two nonpandemic HIV-1 strains (YBF30 and DJO0131). Humanized mice infected with SIVcpz strain MB897, a virus phylogenetically similar to pandemic HIV-1, exhibited a peak viral load comparable to that of mice infected with pandemic HIV-1, while peak viral loads of mice infected with SIVcpz strain EK505 or MT145 as well as nonpandemic HIV-1 strains were significantly lower. These results suggest that SIVcpz strain MB897 is preadapted to humans, unlike the other SIVcpz strains. Moreover, viral RNA sequencing of MB897-infected humanized mice identified a nonsynonymous mutation in env, a G413R substitution in gp120. The infectivity of the gp120 G413R mutant of MB897 was significantly higher than that of parental MB897. Furthermore, we demonstrated that the gp120 G413R mutant of MB897 augments the capacity for viral replication in both in vitro cell cultures and humanized mice. Taken together, this is the first experimental investigation to use an animal model to demonstrate a gain-of-function evolution of SIVcpz into pandemic HIV-1.IMPORTANCE From the mid-20th century, humans have been exposed to the menace of infectious viral diseases, such as severe acute respiratory syndrome coronavirus, Ebola virus, and Zika virus. These outbreaks of emerging/reemerging viruses can be triggered by cross-species viral transmission from wild animals to humans, or zoonoses. HIV-1, the causative agent of AIDS, emerged by the cross-species transmission of SIVcpz, the HIV-1 precursor in chimpanzees, around 100 years ago. However, the process by which SIVcpz evolved to become HIV-1 in humans remains unclear. Here, by using a hematopoietic stem cell-transplanted humanized-mouse model, we experimentally recapitulate the evolutionary process of SIVcpz to become HIV-1. We provide evidence suggesting that a strain of SIVcpz, MB897, preadapted to infect humans over other SIVcpz strains. We further demonstrate a gain-of-function evolution of SIVcpz in infected humanized mice. Our study reveals that pandemic HIV-1 has emerged through at least two steps: preadaptation and subsequent gain-of-function mutations.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  HIV-1; SIVcpz; cross-species transmission; humanized mouse; viral evolution

Mesh:

Substances:

Year:  2018        PMID: 29212937      PMCID: PMC5790958          DOI: 10.1128/JVI.01905-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  78 in total

Review 1.  Immune evasion and counteraction of restriction factors by HIV-1 and other primate lentiviruses.

Authors:  Frank Kirchhoff
Journal:  Cell Host Microbe       Date:  2010-07-22       Impact factor: 21.023

Review 2.  BST-2/tetherin: a new component of the innate immune response to enveloped viruses.

Authors:  David T Evans; Ruth Serra-Moreno; Rajendra K Singh; John C Guatelli
Journal:  Trends Microbiol       Date:  2010-08-03       Impact factor: 17.079

3.  Efficient SIVcpz replication in human lymphoid tissue requires viral matrix protein adaptation.

Authors:  Frederic Bibollet-Ruche; Anke Heigele; Brandon F Keele; Juliet L Easlick; Julie M Decker; Jun Takehisa; Gerald Learn; Paul M Sharp; Beatrice H Hahn; Frank Kirchhoff
Journal:  J Clin Invest       Date:  2012-04-16       Impact factor: 14.808

4.  NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells.

Authors:  Mamoru Ito; Hidefumi Hiramatsu; Kimio Kobayashi; Kazutomo Suzue; Mariko Kawahata; Kyoji Hioki; Yoshito Ueyama; Yoshio Koyanagi; Kazuo Sugamura; Kohichiro Tsuji; Toshio Heike; Tatsutoshi Nakahata
Journal:  Blood       Date:  2002-11-01       Impact factor: 22.113

5.  Modulation of human immunodeficiency virus type 1 infectivity through incorporation of tetraspanin proteins.

Authors:  Kei Sato; Jun Aoki; Naoko Misawa; Eriko Daikoku; Kouichi Sano; Yuetsu Tanaka; Yoshio Koyanagi
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

6.  Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu.

Authors:  Stuart J D Neil; Trinity Zang; Paul D Bieniasz
Journal:  Nature       Date:  2008-01-16       Impact factor: 49.962

7.  Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains.

Authors:  Daniel Sauter; Michael Schindler; Anke Specht; Wilmina N Landford; Jan Münch; Kyeong-Ae Kim; Jörg Votteler; Ulrich Schubert; Frederic Bibollet-Ruche; Brandon F Keele; Jun Takehisa; Yudelca Ogando; Christina Ochsenbauer; John C Kappes; Ahidjo Ayouba; Martine Peeters; Gerald H Learn; George Shaw; Paul M Sharp; Paul Bieniasz; Beatrice H Hahn; Theodora Hatziioannou; Frank Kirchhoff
Journal:  Cell Host Microbe       Date:  2009-11-19       Impact factor: 21.023

8.  Quantifying the effect of Vpu on the promotion of HIV-1 replication in the humanized mouse model.

Authors:  Hiroki Ikeda; Shinji Nakaoka; Rob J de Boer; Satoru Morita; Naoko Misawa; Yoshio Koyanagi; Kazuyuki Aihara; Kei Sato; Shingo Iwami
Journal:  Retrovirology       Date:  2016-04-18       Impact factor: 4.602

9.  Emerging pathogens: the epidemiology and evolution of species jumps.

Authors:  Mark E J Woolhouse; Daniel T Haydon; Rustom Antia
Journal:  Trends Ecol Evol       Date:  2005-05       Impact factor: 17.712

10.  The SWISS-MODEL Repository and associated resources.

Authors:  Florian Kiefer; Konstantin Arnold; Michael Künzli; Lorenza Bordoli; Torsten Schwede
Journal:  Nucleic Acids Res       Date:  2008-10-18       Impact factor: 16.971

View more
  11 in total

1.  A glycan shield on chimpanzee CD4 protects against infection by primate lentiviruses (HIV/SIV).

Authors:  Cody J Warren; Nicholas R Meyerson; Alex C Stabell; Will T Fattor; Gregory K Wilkerson; Sara L Sawyer
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-21       Impact factor: 11.205

2.  SIVcpz cross-species transmission and viral evolution toward HIV-1 in a humanized mouse model.

Authors:  James Curlin; Kimberly Schmitt; Leila Remling-Mulder; Ryan Moriarty; Mark Stenglein; Shelby O'Connor; Preston Marx; Ramesh Akkina
Journal:  J Med Primatol       Date:  2019-10-01       Impact factor: 0.667

3.  Evolution of SIVsm in humanized mice towards HIV-2.

Authors:  James Curlin; Kimberly Schmitt; Leila Remling-Mulder; Ryan Moriarty; Kelly Goff; Shelby O'Connor; Mark Stenglein; Preston Marx; Ramesh Akkina
Journal:  J Med Primatol       Date:  2020-08-10       Impact factor: 0.667

Review 4.  Advances in Humanized Mouse Models to Improve Understanding of HIV-1 Pathogenesis and Immune Responses.

Authors:  Amy Gillgrass; Jocelyn M Wessels; Jack X Yang; Charu Kaushic
Journal:  Front Immunol       Date:  2021-03-05       Impact factor: 7.561

Review 5.  Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D.

Authors:  Ming-Yieh Peng; Wen-Chih Liu; Jing-Quan Zheng; Chien-Lin Lu; Yi-Chou Hou; Cai-Mei Zheng; Jenn-Yeu Song; Kuo-Cheng Lu; You-Chen Chao
Journal:  Int J Mol Sci       Date:  2021-05-16       Impact factor: 5.923

6.  Cross-Species Transmission and Evolution of SIV Chimpanzee Progenitor Viruses Toward HIV-1 in Humanized Mice.

Authors:  Kimberly Schmitt; James Curlin; Leila Remling-Mulder; Ryan Moriarty; Kelly Goff; Shelby O'Connor; Mark Stenglein; Preston Marx; Ramesh Akkina
Journal:  Front Microbiol       Date:  2020-08-11       Impact factor: 5.640

Review 7.  Humanized Mouse Models for the Study of Infection and Pathogenesis of Human Viruses.

Authors:  Fritz Lai; Qingfeng Chen
Journal:  Viruses       Date:  2018-11-17       Impact factor: 5.048

8.  Site-Specific Evolutionary Rate Shifts in HIV-1 and SIV.

Authors:  Maoz Gelbart; Adi Stern
Journal:  Viruses       Date:  2020-11-16       Impact factor: 5.048

9.  A role for gorilla APOBEC3G in shaping lentivirus evolution including transmission to humans.

Authors:  Yusuke Nakano; Keisuke Yamamoto; Mahoko Takahashi Ueda; Andrew Soper; Yoriyuki Konno; Izumi Kimura; Keiya Uriu; Ryuichi Kumata; Hirofumi Aso; Naoko Misawa; Shumpei Nagaoka; Soma Shimizu; Keito Mitsumune; Yusuke Kosugi; Guillermo Juarez-Fernandez; Jumpei Ito; So Nakagawa; Terumasa Ikeda; Yoshio Koyanagi; Reuben S Harris; Kei Sato
Journal:  PLoS Pathog       Date:  2020-09-10       Impact factor: 6.823

Review 10.  Importance of Dietary Changes During the Coronavirus Pandemic: How to Upgrade Your Immune Response.

Authors:  Ali Chaari; Ghizlane Bendriss; Dalia Zakaria; Clare McVeigh
Journal:  Front Public Health       Date:  2020-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.